Addiction · 1993 · 50 citations · 22 references
Public HealthPharmacotherapySubstance Use DisordersSubstance Use PreventionTobacco ControlNicotine DependenceRelapse PreventionSmoking CessationTobacco CessationTobacco UseTobacco Use CessationCessation EfficacyNicotine Patch TherapyNicotine Replacement Therapy PatchesRelapse After CessationSmoking Abstinence MaintenanceSmoking Cessation MaintenanceSustained AbstinenceTobacco Relapse
The aim was to evaluate if recycling of failures from a smoking cessation study may be of value. The study comprised 126 smokers (50%) of 252 failures, from a double-blind smoking cessation trial with nicotine patch, who accepted recycling after 1 year. Subjects were allocated nicotine patches delivering 15, 20 or 25 mg of nicotine (over 16 hours) according to their base-line saliva cotinine concentrations in an open trial. The treatment period was 12 weeks followed by tapering over 6 weeks. The percentage of quitters after 3, 12, 26, and 52 weeks was 44, 20, 7 and 6%, respectively. After 26 weeks, all subjects had relapsed in the group previously treated with active nicotine patch compared with 12% abstainers in the previous placebo subjects. The sustained abstinence rate without slips after one year was 2%. Recycling does not seem to be of long-term clinical relevance in our set-up for subjects initially treated with nicotine, but of some value in subjects quitting without nicotine therapy initially.
22
Diagnostic and Statistical Manual of Mental Disorders
&NA; · Alzheimer Disease & Associated Disorders · 1988 · 12.7K citations
Medicine, Pediatrics, Psychiatry +4
Transdermal Nicotine for Smoking Cessation
Arden G. Christen · JAMA · 1991 · 302 citations